In addition to redox modulation of intracellular Ca2+ homeostasis, mitoROS can also promote AF through perpetuating inflammation via activating the NLRP3 inflammasome and driving release of inflammatory cytokines, such as IL-1β and IL-18 (64). The gene discussed is NLRP3; the disease is atrial fibrillation.